drugset
drugset / Trial / NCT04829799

Effect of Intracameral Phenylephrine/Ketorolac on Intraoperative Pain

NCT04829799 ↗

Phase 4 Withdrawn University of Florida Omeros Corporation · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

To compare the effect of intraoperative intracameral Omidria (Phenylephrine and Ketorolac 1.0%/0.3%) verses 1% Lidocaine on pain reduction during and after cataract surgery.

Timeline

Start
2022-02
Primary completion
2023-08
Completion
2023-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Other / unclassified 0.3 % Other
Comparator Lidocaine Other / unclassified 1 % Other
Subject Phenylephrine Small molecule 1 % Other

Indications

No indication recorded.